Brief report
Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine

https://doi.org/10.1016/0735-6757(94)90061-2Get rights and content

Abstract

Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg Intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients compieted before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (± standard error of the mean) dropped from 6.43 (±1.25), out of a possible 10, to 1.01 (±.35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.

References (12)

  • HS Diamond

    Control of crystal induced arthropathies

    Rheum Dis Clin North Am

    (1989)
  • EC Huskisson

    The measurement of pain

    Lancet

    (1974)
  • WM Kelly et al.

    Gout and related disorders of purine metabolism

  • MH Arnold et al.

    Comparison of the natural history of untreated gouty arthritis vs acute gouty arthritis treated with non-steroidal-anti-inflammatory drugs

    Br J Clin Pharmacol

    (1988)
  • ASC Rice et al.

    A double-blind study of the speed of onset of analgesia following intramuscular administration of ketorolac tromethamine in comparison to intramuscular morphine and placebo

    Anaesthesia

    (1991)
  • GWA Gillies et al.

    The morphine sparing effect of ketorolac tromethamine

    Anaesthesia

    (1987)
There are more references available in the full text version of this article.

Cited by (0)

View full text